+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Ankylosing Spondylitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767663
  • Report
  • April 2019
  • Region: Global
  • 195 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Biocad
  • Johnson & Johnson
  • Merck & Co Inc
  • Novartis AG
  • MORE
The global clinical trial report- “2019 Ankylosing Spondylitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ankylosing Spondylitis. It presents in-depth analysis of Ankylosing Spondylitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Ankylosing Spondylitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Ankylosing Spondylitis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Ankylosing Spondylitis

The research work is prepared through extensive and continuous research on Ankylosing Spondylitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Ankylosing Spondylitis patients are identified
  • The report includes panorama of Ankylosing Spondylitis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Ankylosing Spondylitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Biocad
  • Johnson & Johnson
  • Merck & Co Inc
  • Novartis AG
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Ankylosing Spondylitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Ankylosing Spondylitis Clinical Trials by Region
2.2.2 Average Enrollment of Ankylosing Spondylitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Ankylosing Spondylitis Treatment, 2019

3. Region wise Ankylosing Spondylitis Clinical Trials
3.1 Asia Pacific Ankylosing Spondylitis Clinical Trials by Country
3.2 Europe Ankylosing Spondylitis Clinical Trials by Country
3.3 North America Ankylosing Spondylitis Clinical Trials by Country
3.4 Middle East and Africa Ankylosing Spondylitis Clinical Trials by Country
3.5 South and Central America Ankylosing Spondylitis Clinical Trials by Country

4. Ankylosing Spondylitis Clinical Trial Trends
4.1 Start Year wise Ankylosing Spondylitis Clinical Trials
4.2 Phase wise Ankylosing Spondylitis Clinical Trials
4.3 Trial Status wise Ankylosing Spondylitis Clinical Trials
4.4 Trial Type wise Ankylosing Spondylitis Clinical Trials

5. Ankylosing Spondylitis Average Enrollment Trends
5.1 Average Enrollment in Ankylosing Spondylitis Trials by Year
5.2 Average Enrollment in Ankylosing Spondylitis Trials by Phase
5.3 Average Enrollment in Ankylosing Spondylitis Trials by Status
5.4 Average Enrollment in Ankylosing Spondylitis Trials by Type of Trial

6. Companies Participating in Ankylosing Spondylitis Clinical Trials
6.1 Ankylosing Spondylitis Trials by Sponsor Type
6.2 Ankylosing Spondylitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ankylosing Spondylitis Trials- Phase 1
7.2 Ankylosing Spondylitis Trials- Phase 2
7.3 Ankylosing Spondylitis Trials- Phase 3
7.4 Ankylosing Spondylitis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Ankylosing Spondylitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Figure 9: Ankylosing Spondylitis Clinical Trials by Phase
Figure 10: Ankylosing Spondylitis Clinical Trials by Trial Status
Figure 11: Ankylosing Spondylitis Clinical Trials by Type
Figure 12: Ankylosing Spondylitis Clinical Trials by Sponsor Type
Figure 13: Ankylosing Spondylitis Clinical Trials by Leading Sponsors
Figure 14: Ankylosing Spondylitis Average Enrollment by Phase
Figure 15: Ankylosing Spondylitis Average Enrollment by Trial Status
Figure 16: Ankylosing Spondylitis Average Enrollment by Type
Figure 17: Ankylosing Spondylitis- Average Enrolment by Type of Sponsors
Figure 18: Ankylosing Spondylitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Ankylosing Spondylitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 7: North America - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Ankylosing Spondylitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Ankylosing Spondylitis Average Enrollment by Phase
Table 15: Ankylosing Spondylitis Average Enrollment by Trial Status
Table 16: Ankylosing Spondylitis Average Enrollment by Type
Table 17: Ankylosing Spondylitis- Average Enrolment by Type of Sponsors
Table 18: Ankylosing Spondylitis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AbbVie Inc
  • Amgen Inc
  • Biocad
  • C. H. Boehringer Sohn AG & Co KG
  • Johnson & Johnson
  • Merck & Co Inc
  • Novartis AG
  • Pamplona Capital Management LLP
  • Pfizer Inc
  • UCB SA
Note: Product cover images may vary from those shown
Adroll
adroll